ANI Pharmaceuticals (ANIP) Competitors $69.21 +0.01 (+0.01%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$69.22 +0.01 (+0.01%) As of 04/17/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIP vs. BBIO, LEGN, BPMC, SRPT, TLX, AXSM, KRYS, NUVL, GRFS, and ELANShould you be buying ANI Pharmaceuticals stock or one of its competitors? The main competitors of ANI Pharmaceuticals include BridgeBio Pharma (BBIO), Legend Biotech (LEGN), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Axsome Therapeutics (AXSM), Krystal Biotech (KRYS), Nuvalent (NUVL), Grifols (GRFS), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. ANI Pharmaceuticals vs. BridgeBio Pharma Legend Biotech Blueprint Medicines Sarepta Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Axsome Therapeutics Krystal Biotech Nuvalent Grifols Elanco Animal Health BridgeBio Pharma (NASDAQ:BBIO) and ANI Pharmaceuticals (NASDAQ:ANIP) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking. Which has more risk and volatility, BBIO or ANIP? BridgeBio Pharma has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, ANI Pharmaceuticals has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500. Does the MarketBeat Community favor BBIO or ANIP? ANI Pharmaceuticals received 264 more outperform votes than BridgeBio Pharma when rated by MarketBeat users. However, 72.13% of users gave BridgeBio Pharma an outperform vote while only 64.33% of users gave ANI Pharmaceuticals an outperform vote. CompanyUnderperformOutperformBridgeBio PharmaOutperform Votes17672.13% Underperform Votes6827.87% ANI PharmaceuticalsOutperform Votes44064.33% Underperform Votes24435.67% Is BBIO or ANIP more profitable? ANI Pharmaceuticals has a net margin of -1.28% compared to BridgeBio Pharma's net margin of -241.44%. ANI Pharmaceuticals' return on equity of 15.87% beat BridgeBio Pharma's return on equity.Company Net Margins Return on Equity Return on Assets BridgeBio Pharma-241.44% N/A -75.69% ANI Pharmaceuticals -1.28%15.87%6.88% Do analysts prefer BBIO or ANIP? BridgeBio Pharma presently has a consensus price target of $53.00, indicating a potential upside of 56.48%. ANI Pharmaceuticals has a consensus price target of $79.75, indicating a potential upside of 15.23%. Given BridgeBio Pharma's higher probable upside, research analysts plainly believe BridgeBio Pharma is more favorable than ANI Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BridgeBio Pharma 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92ANI Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media refer more to BBIO or ANIP? In the previous week, ANI Pharmaceuticals had 5 more articles in the media than BridgeBio Pharma. MarketBeat recorded 21 mentions for ANI Pharmaceuticals and 16 mentions for BridgeBio Pharma. BridgeBio Pharma's average media sentiment score of 0.91 beat ANI Pharmaceuticals' score of 0.89 indicating that BridgeBio Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BridgeBio Pharma 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ANI Pharmaceuticals 10 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, BBIO or ANIP? ANI Pharmaceuticals has higher revenue and earnings than BridgeBio Pharma. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than BridgeBio Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBridgeBio Pharma$221.90M29.03-$535.76M-$2.85-11.88ANI Pharmaceuticals$614.38M2.45$18.78M-$1.14-60.71 Do insiders and institutionals believe in BBIO or ANIP? 99.8% of BridgeBio Pharma shares are owned by institutional investors. Comparatively, 76.1% of ANI Pharmaceuticals shares are owned by institutional investors. 24.7% of BridgeBio Pharma shares are owned by company insiders. Comparatively, 12.7% of ANI Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryANI Pharmaceuticals beats BridgeBio Pharma on 10 of the 19 factors compared between the two stocks. Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIP vs. The Competition Export to ExcelMetricANI PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.51B$6.44B$5.29B$7.35BDividend YieldN/A3.23%5.12%4.31%P/E Ratio-125.846.8821.7317.77Price / Sales2.45231.02379.1697.65Price / Cash9.0365.6738.2234.64Price / Book3.285.916.443.98Net Income$18.78M$142.72M$3.21B$247.44M7 Day Performance1.60%4.33%2.81%1.82%1 Month Performance7.77%-12.80%-8.67%-6.98%1 Year Performance7.17%-9.71%11.32%1.49% ANI Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIPANI Pharmaceuticals3.623 of 5 stars$69.21+0.0%$79.75+15.2%+5.7%$1.51B$614.38M-125.84600Analyst UpgradeBBIOBridgeBio Pharma4.5984 of 5 stars$30.67-2.2%$52.64+71.6%+35.6%$5.83B$221.90M-10.76400Analyst ForecastInsider TradeAnalyst RevisionNews CoverageLEGNLegend Biotech2.4476 of 5 stars$30.25-5.5%$79.00+161.2%-32.8%$5.56B$627.24M-31.841,070Analyst ForecastAnalyst RevisionNews CoveragePositive NewsBPMCBlueprint Medicines2.6717 of 5 stars$80.20-1.8%$124.95+55.8%-4.2%$5.13B$508.82M-74.26640Analyst ForecastAnalyst RevisionNews CoverageSRPTSarepta Therapeutics4.6759 of 5 stars$52.40-3.7%$163.18+211.4%-54.4%$5.08B$1.90B41.92840Analyst ForecastShort Interest ↑Gap DownHigh Trading VolumeTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$14.25+4.7%$22.00+54.4%N/A$4.81B$783.21M0.00N/AAXSMAxsome Therapeutics4.5719 of 5 stars$98.50-0.4%$169.80+72.4%+49.8%$4.80B$385.69M-16.44380Analyst RevisionKRYSKrystal Biotech4.7151 of 5 stars$166.01-3.1%$220.00+32.5%-0.6%$4.78B$290.52M55.52210Positive NewsNUVLNuvalent1.7556 of 5 stars$64.68-1.6%$113.44+75.4%+11.5%$4.63BN/A-18.6440Insider TradeNews CoveragePositive NewsGRFSGrifols3.0942 of 5 stars$6.55-1.5%N/A+7.6%$4.50B$7.21B5.6026,300Gap DownELANElanco Animal Health4.3434 of 5 stars$8.95-2.2%$15.17+69.6%-37.0%$4.44B$4.44B22.369,800 Related Companies and Tools Related Companies BridgeBio Pharma Alternatives Legend Biotech Alternatives Blueprint Medicines Alternatives Sarepta Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Axsome Therapeutics Alternatives Krystal Biotech Alternatives Nuvalent Alternatives Grifols Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIP) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe Last Time Stocks Looked Like This, They Didn’t Move For 16 YearsThere is nothing the Federal Reserve can do to stop what's coming next for U.S. stocks. As you've seen your...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIP Stock Free ANIP Stock Alerts